WeVote
Log In

Bill

Bill

H 763

An Act relative to assessing the feasibility of in-state drug manufacturing

194th Legislature (2025-2026) Introduced by Marjorie Decker and 2 co-sponsors

Massachusetts will study the feasibility of establishing in-state pharmaceutical manufacturing to improve drug access and supply chain resilience.

Discharged to the committee on House Rules
0
WeVote Research Nonpartisan
Bill Summary · H 763

Legislative bill overview

H 763 directs Massachusetts to conduct a comprehensive feasibility study on establishing in-state pharmaceutical manufacturing capabilities. The bill requires an assessment of infrastructure, regulatory requirements, cost-benefit analysis, and potential locations for drug production facilities within the state.

Why is this important

In-state drug manufacturing could reduce Massachusetts' dependence on out-of-state and international supply chains, potentially lowering medication costs and improving access to critical drugs. It also represents a significant economic development opportunity, creating manufacturing jobs and establishing the state as a pharmaceutical production hub while addressing drug supply chain vulnerabilities exposed during recent crises.

Potential points of contention

  • Cost and feasibility concerns: Building pharmaceutical manufacturing infrastructure requires substantial capital investment and meets stringent FDA regulations; the study may reveal prohibitive costs that make in-state production economically unviable compared to existing supply chains.
  • Competition with existing industry: Massachusetts has a strong pharmaceutical research sector; manufacturers may argue that production facilities would compete for resources and talent without clear market advantage over established facilities.
  • Regulatory complexity: State-level manufacturing would still require federal FDA oversight, and it's unclear whether Massachusetts can offer advantages over existing regulated manufacturers, potentially limiting the practical benefit of this initiative.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.